A Risk-Benefit Assessment of Agents Used in the Treatment of Scabies
- 1 June 1996
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 14 (6) , 386-393
- https://doi.org/10.2165/00002018-199614060-00004
Abstract
Permethrin is probably the most effective topical treatment for scabies. There is little microbial resistance to the drug, and it is highly effective. Toxicity is limited to occasional contact dermatitis. Similarly, oral ivermectin 200 µg/kg is extremely effective. Oral administration eliminates the need to be certain that medication has been applied properly. Toxicity has been very limited. It is not available in the US for human use in scabies at this time. The toxicity of most of other treatments that are available has not been studied carefully. Sulphur 6% in petrolatum is recommended as safe, but there are no good studies to confirm this. Sulphur is probably the medication of choice when cost is the overriding concern. Crotamiton and benzyl benzoate are probably safe, but are not as effective as permethrin. Lindane has some potential CNS toxicity if used incorrectly, and must be used carefully on damaged skin to avoid excessive absorption. It is important to stress that all household and sexual contacts must be treated, whether or not they have symptoms. Proper application of topical medications must be achieved, including under the fingernails, and up to the edge of all body orifices.Keywords
This publication has 39 references indexed in Scilit:
- Lindane-resistant scabiesJournal of the American Academy of Dermatology, 1992
- Scabies resistant to lindane 1% lotion and crotamiton 10% creamJournal of the American Academy of Dermatology, 1991
- Sulfur revisitedJournal of the American Academy of Dermatology, 1990
- Comparison of Crotamiton 10% Cream (Eurax) and Permethrin 5% Cream (Elimite) for the Treatment of Scabies in ChildrenPediatric Dermatology, 1990
- Sulfur revisitedJournal of the American Academy of Dermatology, 1988
- Permethrin 5% dermal cream: A new treatment far scabiesJournal of the American Academy of Dermatology, 1986
- Survival and infestivity of Sarcoptes scabiei var. canis and var. hominisJournal of the American Academy of Dermatology, 1984
- A comparative trial of three treatment schedules for the eradication of scabiesJournal of the American Academy of Dermatology, 1983
- The problem of lindaneJournal of the American Academy of Dermatology, 1981
- Treatment of Scabies: Preliminary ReportInternational Journal of Dermatology, 1981